289 related articles for article (PubMed ID: 10228054)
1. Cytomegalovirus (CMV) resistance in patients with CMV retinitis and AIDS treated with oral or intravenous ganciclovir.
Drew WL; Stempien MJ; Andrews J; Shadman A; Tan SJ; Miner R; Buhles W
J Infect Dis; 1999 Jun; 179(6):1352-5. PubMed ID: 10228054
[TBL] [Abstract][Full Text] [Related]
2. Intraocular therapy for cytomegalovirus retinitis.
Palestine AG
J Int Assoc Physicians AIDS Care; 1996 May; 2(5):25-8. PubMed ID: 11363527
[TBL] [Abstract][Full Text] [Related]
3. Emergence of drug-resistant cytomegalovirus retinitis in the contralateral eyes of patients with AIDS treated with ganciclovir.
Imai Y; Shum C; Martin DF; Kuppermann BD; Drew WL; Margolis TP
J Infect Dis; 2004 Feb; 189(4):611-5. PubMed ID: 14767813
[TBL] [Abstract][Full Text] [Related]
4. [Ganciclovir-resistant cytomegalovirus infection: 2 cases with different clinical impact].
Reusser P; Hostettler B; Attehbofer R
Schweiz Med Wochenschr; 1996 Oct; 126(42):1779-84. PubMed ID: 8966510
[TBL] [Abstract][Full Text] [Related]
5. Oral ganciclovir for cytomegalovirus retinitis in patients with AIDS: results of two randomized studies.
Squires KE
AIDS; 1996 Dec; 10 Suppl 4():S13-8. PubMed ID: 9110065
[TBL] [Abstract][Full Text] [Related]
6. Ganciclovir implants: one year later.
Cadman J
GMHC Treat Issues; 1997; 11(4/5):3-6. PubMed ID: 11364375
[TBL] [Abstract][Full Text] [Related]
7. Cytomegalovirus retinitis in AIDS patients: a comparative study of intravenous and oral ganciclovir as maintenance therapy.
Danner SA; Matheron S
AIDS; 1996 Dec; 10 Suppl 4():S7-11. PubMed ID: 9110064
[TBL] [Abstract][Full Text] [Related]
8. Mutations conferring ganciclovir resistance in a cohort of patients with acquired immunodeficiency syndrome and cytomegalovirus retinitis.
Jabs DA; Martin BK; Forman MS; Dunn JP; Davis JL; Weinberg DV; Biron KK; Baldanti F;
J Infect Dis; 2001 Jan; 183(2):333-337. PubMed ID: 11120934
[TBL] [Abstract][Full Text] [Related]
9. Valganciclovir: new preparation. CMV retinitis: a simpler, oral treatment.
Prescrire Int; 2003 Aug; 12(66):133-5. PubMed ID: 12906021
[TBL] [Abstract][Full Text] [Related]
10. A deletion mutation in region V of the cytomegalovirus DNA polymerase sequence confers multidrug resistance.
Chou S; Miner RC; Drew WL
J Infect Dis; 2000 Dec; 182(6):1765-8. PubMed ID: 11069251
[TBL] [Abstract][Full Text] [Related]
11. Therapy with a combination of intravitreal foscarnet and intravenous ganciclovir in clinically resistant cytomegalovirus retinitis and patients with acquired immunodeficiency syndrome.
Guembel HO; Hofmann F; van Even G; Cinatl J; Makabe R
Ger J Ophthalmol; 1996 Nov; 5(6):490-1. PubMed ID: 9479542
[No Abstract] [Full Text] [Related]
12. Change over time in incidence of ganciclovir resistance in patients with cytomegalovirus retinitis.
Martin BK; Ricks MO; Forman MS; Jabs DA;
Clin Infect Dis; 2007 Apr; 44(7):1001-8. PubMed ID: 17342657
[TBL] [Abstract][Full Text] [Related]
13. Ganciclovir evaluation in AIDS patients with cytomegalovirus retinitis: a European study of treatment patterns and resource utilization.
Hardens M
AIDS; 1996 Dec; 10 Suppl 4():S25-30. PubMed ID: 9110067
[TBL] [Abstract][Full Text] [Related]
14. Intravenous versus oral ganciclovir: European/Australian comparative study of efficacy and safety in the prevention of cytomegalovirus retinitis recurrence in patients with AIDS. The Oral Ganciclovir European and Australian Cooperative Study Group.
AIDS; 1995 May; 9(5):471-7. PubMed ID: 7639972
[TBL] [Abstract][Full Text] [Related]
15. Oral ganciclovir.
Schouten JT
STEP Perspect; 1995; 7(3):1, 11. PubMed ID: 11362979
[TBL] [Abstract][Full Text] [Related]
16. Cytomegalovirus retinitis and viral resistance. Prevalence of resistance at diagnosis, 1994. Cytomegalovirus Retinitis and Viral Resistance Study Group.
Jabs DA; Dunn JP; Enger C; Forman M; Bressler N; Charache P
Arch Ophthalmol; 1996 Jul; 114(7):809-14. PubMed ID: 8660163
[TBL] [Abstract][Full Text] [Related]
17. Cytomegalovirus UL97 mutations associated with ganciclovir resistance in immunocompromised patients from Argentina.
Sánchez Puch S; Ochoa C; Carballal G; Zala C; Cahn P; Brunet R; Salomón H; Videla C
J Clin Virol; 2004 Jul; 30(3):271-5. PubMed ID: 15135748
[TBL] [Abstract][Full Text] [Related]
18. Mutations conferring foscarnet resistance in a cohort of patients with acquired immunodeficiency syndrome and cytomegalovirus retinitis.
Weinberg A; Jabs DA; Chou S; Martin BK; Lurain NS; Forman MS; Crumpacker C; ;
J Infect Dis; 2003 Mar; 187(5):777-84. PubMed ID: 12599051
[TBL] [Abstract][Full Text] [Related]
19. Funduscopy versus photographic assessment of cytomegalovirus retinitis progression: a clinician's perspective.
Migdal C
AIDS; 1996 Dec; 10 Suppl 4():S19-23. PubMed ID: 9110066
[TBL] [Abstract][Full Text] [Related]
20. Protease inhibitors linked to drop in CMV retinitis.
AIDS Alert; 1997 Aug; 12(8):92-4. PubMed ID: 11364475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
